A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging.
Because human mesenchymal stem cells (hMSC) have profound immunomodulatory effects, many attempts have been made to use hMSCs in preclinical and clinical trials. For hMSCs to be used in therapy, a large population of hMSCs must be generated by in vitro expansion. However, the immunomodulatory change...
Main Authors: | Kyung-Rok Yu, Jin Young Lee, Hyung-Sik Kim, In-Sun Hong, Soon Won Choi, Yoojin Seo, Insung Kang, Jae-Jun Kim, Byung-Chul Lee, SeungHee Lee, Andreas Kurtz, Kwang-Won Seo, Kyung-Sun Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4121064?pdf=render |
Similar Items
-
Correction: A p38 MAPK-Mediated Alteration of COX-2/PGE2 Regulates Immunomodulatory Properties in Human Mesenchymal Stem Cell Aging
by: The Staff
Published: (2014-01-01) -
Correction: A p38 MAPK-Mediated Alteration of COX-2/PGE Regulates Immunomodulatory Properties in Human Mesenchymal Stem Cell Aging.
Published: (2014-01-01) -
Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
by: Yoojin Seo, et al.
Published: (2019-01-01) -
REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells.
by: Dilli Ram Bhandari, et al.
Published: (2010-05-01) -
Nontypeable <it>Haemophilus influenzae </it>induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B
by: Koga Tomoaki, et al.
Published: (2008-01-01)